Standard Biotools (LAB) Assets Average (2016 - 2025)
Standard Biotools (LAB) has disclosed Assets Average for 15 consecutive years, with $553.7 million as the latest value for Q4 2025.
- Quarterly Assets Average fell 14.41% to $553.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $553.7 million through Dec 2025, down 14.41% year-over-year, with the annual reading at $590.0 million for FY2025, 26.16% up from the prior year.
- Assets Average for Q4 2025 was $553.7 million at Standard Biotools, up from $548.3 million in the prior quarter.
- The five-year high for Assets Average was $743.2 million in Q2 2024, with the low at $273.6 million in Q1 2022.
- Average Assets Average over 5 years is $448.1 million, with a median of $391.8 million recorded in 2022.
- The sharpest move saw Assets Average soared 104.32% in 2024, then decreased 23.54% in 2025.
- Over 5 years, Assets Average stood at $278.7 million in 2021, then skyrocketed by 44.46% to $402.6 million in 2022, then decreased by 17.74% to $331.2 million in 2023, then skyrocketed by 95.35% to $646.9 million in 2024, then fell by 14.41% to $553.7 million in 2025.
- According to Business Quant data, Assets Average over the past three periods came in at $553.7 million, $548.3 million, and $568.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.